MICAFUNGIN SODIUM
BIOCON PHARMA · MICAFUNGIN SODIUM
Open FDA's page for this record- Application number
- ANDA216438
- Sponsor name
- BIOCON PHARMA
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20240529
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Products
- Product number
- 001
- Reference drug
- No
- Brand name
- MICAFUNGIN SODIUM
- Reference standard
- No
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Te code
- AP
- Active ingredients
- Name
- MICAFUNGIN SODIUM
- Strength
- EQ 50MG BASE/VIAL
- Product number
- 002
- Reference drug
- No
- Brand name
- MICAFUNGIN SODIUM
- Reference standard
- No
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Te code
- AP
- Active ingredients
- Name
- MICAFUNGIN SODIUM
- Strength
- EQ 100MG BASE/VIAL
- Harmonized identifiers (openFDA)
- Application number
- ANDA216438
- Brand name
- MICAFUNGIN
- Generic name
- MICAFUNGIN
- Manufacturer name
- Biocon Pharma Inc.
- Product NDC
- 70377-075, 70377-076
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- MICAFUNGIN SODIUM
- RxCUI
- 861379, 861383
- SPL ID
- 94972438-1ece-f99c-c2a5-e29821e7e9d4
- SPL set ID
- 5a74d7e9-1ca2-37dd-cbcf-d7fde1f5a606
- Package NDC
- 70377-075-91, 70377-076-91
- UNII
- IS1UP79R56
